Cargando…
Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
Chemotherapy is the most common clinical treatment for non-small cell lung cancer (NSCLC), but low efficiency and high toxicity of current chemotherapy drugs limit their clinical application. Therefore, it is urgent to develop hypotoxic and efficient chemotherapy drugs. Theophylline, a natural compo...
Autores principales: | Ye, Jiahui, Mao, Longfei, Xie, Luoyijun, Zhang, Rongjun, Liu, Yulin, Peng, Lizeng, Yang, Jianxue, Li, Qingjiao, Yuan, Miaomiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576520/ https://www.ncbi.nlm.nih.gov/pubmed/34764872 http://dx.doi.org/10.3389/fphar.2021.753676 |
Ejemplares similares
-
Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole
por: Deng, Peng, et al.
Publicado: (2022) -
Discovery of a Series of 1,2,3-Triazole-Containing Erlotinib Derivatives With Potent Anti-Tumor Activities Against Non-Small Cell Lung Cancer
por: Sun, Ge, et al.
Publicado: (2022) -
Discovery of Novel 1,2,3-triazole Derivatives as IDO1 Inhibitors
por: Hou, Xixi, et al.
Publicado: (2022) -
Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
por: Mao, Long-fei, et al.
Publicado: (2020) -
Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity
por: Xie, Huaxia, et al.
Publicado: (2023)